Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 814-338-9 | CAS number: 1913285-57-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- GLP compliance:
- no
- Remarks:
- GLP equivalent
- Type of study:
- direct peptide reactivity assay (DPRA)
- Details on the study design:
- The Direct peptide reactivity Assay (DPRA) is an in chemico test to determine the reactivity of test a
substance towards peptides.
This assay has been validated for a broad range of low-molecular weight chemicals and it was found
to detect reactive skin sensitizers from a broad range of so called applicability domains, i.e.
chemicals reacting with proteins by different mechanisms. It was validated by ECVAM and proposed
to be used as part of an integrated approach for testing and assessment (IATA).
The test substance was dissolved in acetonitrile and mixed with a Cysteine- and a
Lysine-containing peptide according to the standard operating procedure of the DPRA. One study
with three replicates was conducted. After 24 h incubation time, peptide depletion induced by was determined by HPLC-UV. - Key result
- Parameter:
- other: Average depletion Cys-and Lys-peptide
- Value:
- 0.5
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The result of the DPRA assay should be used as part of an integrated approach for testing and assessment (IATA). A parallel test in the KeratinoSens™ assay may indicate whether congruent results are obtained by both test methods. According to a detailed analysis on large set of chemicals, two congruent results in these two tests give a good prediction of the sensitizer hazard [3-5] particularly when predicting human data, while an additional test in a dendritic cell line assessing expression of surface markers may be needed in case of discordant results.
The test substance was non-reactive and classified into the MINIMAL reactivity class according to the prediction model. It is therefore considered a non-sensitizer according to the prediction model of the DPRA. - Executive summary:
The test substance was not reactive in the DPRA assay and can be considered a non-sensitiser in this assay.
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- GLP compliance:
- no
- Remarks:
- GLP equivalence
- Type of study:
- activation of keratinocytes
- Details on the study design:
- The KeratinoSensTM assay is a cell-based assay with a reporter cell line to detect potential skin
sensitizers by their ability to induce the Nrf2-response.
This assay has been validated for a broad range of low-molecular weight chemicals and it was found
to respond to skin sensitizers from a broad range of so called applicability domains, i.e. chemicals
reacting with proteins by different mechanisms. It was validated by ECVAM and proposed to be
used as part of an integrated approach for testing and assessment (IATA).
The test substance was dissolved in DMSO and tested according to the standard
operating procedure of the KeratinoSensTM assay at 12 concentrations in three repetitions, each
time in three replicates. After 48 h incubation time, luciferase induction and cellular viability at each
of the concentrations were determined. - Positive control results:
- Cinnamic aldehyde was run in all three repetitions. Here the detailed results for this positive control
are reported in Table 8 and Figure 5. Cinnamic aldehyde needs to be positive for a run to be
accepted (i.e. induction > 1.5 fold). This was the case in all three repetitions. The induction at 64 μM
and the EC 1.5 for cinnamic aldehyde were also calculated. The targets are: (i) Average induction in
the three replicates for cinnamic aldehyde at 64 μM should be between 2 and 8, and (ii) the EC 1.5
value should be between 7 μM and 30 μM. At least one of these two numerical criteria must be met
in order to accept a repetition. In the experiments performed here both criteria were fulfilled in all
three repetitions. Thus all three repetitions were valid for the positive control. - Key result
- Run / experiment:
- other: 1
- Parameter:
- other: IMAX (fold induction)
- Value:
- 1.21
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The result of the KeratinoSens™ assay should be used as part of an integrated approach for testing
and assessment (IATA)[9]. A parallel test in the DPRA may indicate whether congruent results are
obtained by both test methods. According to a detailed analysis on large set of substances, two
congruent results in these two tests give a good prediction of the sensitizer hazard [5, 7, 18], in
particular when comparing against human data, while an additional test in a dendritic cell line
assessing expression of surface markers may be needed in case of discordant results.
In all three repetitions, no induction of the luciferase above the threshold of 1.5 was noted.
According to the prediction model of the KeratinoSens™ assay, the test substance is rated as nonsensitizer.
This conclusion is also clearly supported by the analysis of the dose-response curve in
Figure 4 with overall no induction of the luciferase reporter gene to be observed. - Executive summary:
No induction was seen in the KeratinosensTM assay and the substance can be considered as non sensitising in this assay.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Justification for classification or non-classification
The result of the KeratinoSens™ and DPRA assays should be used as part of an integrated approach for testing
and assessment (IATA). According to a detailed analysis on large set of substances, two
congruent results in these two tests give a good prediction of the sensitizer hazard, in
particular when comparing against human data, while an additional test in a dendritic cell line
assessing expression of surface markers may be needed in case of discordant results.
In both assays, this substance showed no evidence of reactivity and is not sensitising. Therefore it can be considered with confidence that this substance is not a skin sensitiser in humans.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.